Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)
Recruiting now · Not applicable
Conditions studied: Cholangiocarcinoma, Multiple Myeloma, Colon Cancer, Rectal Cancer
In brief
The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.
Key facts
- Study ID
- NCT06340646
- Run by
- Washington University School of Medicine
- People needed
- 990
- Starts
- 2022-10-18
- Expected to finish
- 2027-01-31
- Last updated by the study team
- 2026-07-14
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Washington University School of Medicine — St Louis, Missouri, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.